Uploaded February 2026 | Updated September 2026, 3 weeks ago

---

Dr. Matthew Brown, Chief Scientific Officer at Genomics England, shares results from a pilot project with Illumina Protein Prep, screening ~1500 participants with rare diseases to demonstrate the power of NGS-based proteomics for biomarker discovery. 

Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.

To learn more about Illumina Protein Prep, visit illumina.com/proteinprep

For research use only. Not for diagnostic purposes.

View customer spotlight videos
youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79

View Illumina webinars
youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ

View Illumina support videos
youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM

LinkedIn: linkedin.com/company/illumina
X: https://x.com/illumina
Instagram: instagram.com/illuminainc
Facebook: facebook.com/illuminainc
TikTok: tiktok.com/@illuminainc

#illumina #multiomics #proteomics #somamer #raredisease